2,326
Participants
Start Date
June 30, 2008
Primary Completion Date
June 30, 2009
Study Completion Date
June 30, 2009
Semuloparin sodium
"0.4 mL (0.2 mL if SRI) solution in ready-to-use 0.5 ml pre-filled syringe~Subcutaneous injection"
Enoxaparin sodium
"0.4 mL (0.2 mL if SRI) solution in ready-to-use 0.5 ml pre-filled syringe~Subcutaneous injection"
Placebo
"0.4 mL (0.2 mL if SRI) solution in ready-to-use 0.5 ml pre-filled syringe strictly identical in appearance but without active component~Subcutaneous injection"
Sanofi-Aventis Administrative Office, Bridgewater
Sanofi-Aventis Administrative Office, Buenos Aires
sanofi-aventis Australia & New Zealand administrative office, Macquarie Park
Sanofi-Aventis Administrative Office, Minsk
Sanofi-Aventis Administrative Office, Laval
Sanofi-Aventis Administrative Office, Santiago
Sanofi-Aventis Administrative Office, Bogotá
Sanofi-Aventis Administrative Office, Prague
Sanofi-Aventis Administrative Office, Hørsholm
Sanofi-Aventis Administrative Office, Tallinn
Sanofi-Aventis Administrative Office, Helsinki
Sanofi-Aventis Administrative Office, Berlin
Sanofi-Aventis Administrative Office, Athens
Sanofi-Aventis Administrative Office, Mumbai
Sanofi-Aventis Administrative Office, Milan
Sanofi-Aventis Administrative Office, México
Sanofi-Aventis Administrative Office, Lysaker
Sanofi-Aventis Administrative Office, Lima
Sanofi-Aventis Administrative Office, Makati City
Sanofi-Aventis Administrative Office, Warsaw
Sanofi-Aventis Administrative Office, Bucharest
Sanofi-Aventis Administrative Office, Moscow
Sanofi-Aventis Administrative Office, Brastislava
Sanofi-Aventis Administrative Office, Midrand
Sanofi-Aventis Administrative Office, Barcelona
Sanofi-Aventis Administrative Office, Bromma
Sanofi-Aventis Administraive Office, Taipei
Sanofi-Aventis Administrative Office, Bangkok
Sanofi-Aventis Administrative Office, Istanbul
Sanofi-Aventis Administrative Office, Kiev
Lead Sponsor
Sanofi
INDUSTRY